A new paradigm for physiologic ventricular pacing
Michael O Sweeney1, Frits W Prinzen
1Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. mosweeney@partners.org
Insights
Conventional right ventricular apex pacing can harm cardiac function and increase heart failure risk. Tailoring pacing strategies to individual patient needs can improve outcomes and reduce cardiac morbidity.
Area of Science:
- Cardiology
- Electrophysiology
- Biomedical Engineering
Background:
- Conventional right ventricular apex (RVA) pacing is linked to ventricular desynchronization, negatively impacting cardiac function.
- This desynchronization increases long-term cardiac morbidity and mortality, even in patients with initially normal heart function.
- Pathophysiological research confirms that RVA pacing leads to abnormal contractions, reduced pump efficiency, and cardiac remodeling.
Purpose of the Study:
- To introduce a new paradigm for individualized ventricular pacing to achieve more physiologic cardiac activation.
- To guide optimization of pacing strategies based on patient-specific conditions like atrioventricular block (AVB) and conduction abnormalities.
- To emphasize the importance of tailored pacing to minimize risks associated with ventricular pacing.
Main Methods:
- Review of clinical trial evidence and pathophysiological research on the effects of ventricular pacing.
- Analysis of outcomes associated with conventional RVA pacing versus alternative pacing sites and modes.
- Development of a patient-tailored pacing strategy framework.
Main Results:
- Ventricular desynchronization from RVA pacing poses a significant risk for heart failure and adverse cardiac events.
- Atrial-based pacing is preferred in patients without AVB or intraventricular conduction abnormalities.
- Alternative pacing strategies (single-site RV, LV, or biventricular pacing) may offer advantages over RVA pacing in patients with AVB.
Conclusions:
- Individualized ventricular pacing strategies are crucial for optimizing cardiac function and reducing long-term risks.
- Pacing optimization efforts should be intensified in patients with anticipated long pacing durations, compromised cardiac function, or significant mechanical dyssynchrony.
- Regular monitoring of cardiac pump function and mechanical synchrony is recommended for all patients with ventricular pacing.
Abstract:
Clinical trials in patients with pacemakers for sinus node dysfunction or atrioventricular block (AVB) and implantable cardioverter-defibrillators provide increasing evidence showing that desynchronization of ventricular electrical activation and contraction, induced by conventional right ventricular apex (RVA) pacing, is a serious threat for long-term cardiac morbidity and mortality. The risk of heart failure is increased even in hearts with initially normal pump function and in case of part-time ventricular pacing. These epidemiologic data fit with knowledge from decades of pathophysiological research, indicating that right ventricular (RV) pacing creates abnormal contraction, reduced pump function, hypertrophy, and ultrastructural abnormalities. This paper presents a new paradigm that aims to tailor ventricular pacing to the individual patient to achieve a way of pacing that is as physiologic as possible. In patients without AVB and no intraventricular conduction abnormalities, ventricular pacing should be avoided as much as possible, using atrial-based pacing. In patients with AVB, alternate single-site RV or left ventricular pacing or biventricular pacing may be superior to RVA pacing. Efforts to optimize the pacing mode or site should be greater in patients with a longer expected duration of pacing, poorer cardiac function, and larger mechanical asynchrony. Awareness of the problem of desynchronization should also lead to more regular monitoring of cardiac pump function and mechanical asynchrony in any patient with ventricular pacing.
Related Concept Videos
Electrophysiology of Normal Cardiac Rhythm
Mechanism of Cardiac Arrhythmias
Conduction System of the Heart
The pacemaker cells are located in two primary nodes: the sinoatrial (SA) node and the atrioventricular (AV) node. The SA node pacemaker cells can autonomously depolarize, triggering an action potential that leads to the...
Conduction System of the Heart
This system relies on the unique properties of nodal and Purkinje cells:...
Cardiac Action Potential
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
Dysrhythmias I: Introduction


